Coadministration of ribavirin and arenaviral entry inhibitor LHF-535 enhances antiviral benefit against authentic lassa virus.

ABSTRACT:

SUBMITTER: Peng C 

PROVIDER: S-EPMC12282416 | biostudies-literature | 2025 Jun

REPOSITORIES: biostudies-literature